Evan Hecker PhD

Evan Hecker, Ph.D. was a CMC Executive of API Development at Spero Therapeutics where he leads all drug substance development and manufacturing for the growing antibiotics pipeline at Spero. Prior to that, he was Director of Process Chemistry at Karyopharm Therapeutics where he led the early clinical API development of their oncology portfolio. Evan started his career in drug development at Cubist Pharmaceuticals after completing a postdoctoral fellowship at Harvard University. He received his B.S. in chemistry from The College of New Jersey and worked briefly in the pharmaceutical industry before returning to school to earn his Ph.D. from the University of Texas at Austin. He and his wife Cara have three very active young boys and Evan has been supporting the mission of A Kids Brain Tumor Cure since his eldest son Nathan was diagnosed with a low-grade tumor at 4 years old. He is eager to help leverage his drug industry experience and network to accelerate any and all research the foundation supports and is committed to finding better drugs and outcomes for our kids battling brain tumors.